Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Novo Nordisk plans to promote the oral form of Wegovy weight-loss drug in markets outside the United States

Novo Nordisk plans to promote the oral form of Wegovy weight-loss drug in markets outside the United States

老虎证券老虎证券2026/05/18 07:42
Show original
Emil Kongshøj Larsen, Executive Vice President for International Operations at Novo Nordisk, stated in an interview: “Once officially launched, we will go all out—this is a tremendous development opportunity.” Following the surge in sales and excellent market response of this oral weight loss drug in the US market, Novo Nordisk announced last week that if regulatory approval is obtained, it expects to begin launching outside the US later this year. Currently, Novo Nordisk and its main competitor Eli Lilly both derive more than half of their sales from the US market. However, in recent years, weight loss drugs have completely reshaped the pharmaceutical industry landscape, and both companies are now increasingly proactive in expanding their market presence abroad.Larsen did not reveal which countries would be the first to see an overseas launch of Wegovy oral tablets. He said pharmaceutical companies would strategize based on market potential, while also considering local obesity patient needs, physician expertise, and telemedicine collaboration resources.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Wall Street’s most steadfast bull warns: If oil prices and the bond market worsen, the S&P 500 may first drop to 7,100 points.

Morgan Stanley strategists warn of risks in the energy and bond markets, stating that the S&P 500 may fall by 7% to 7100 points, but they remain optimistic about an earnings-driven rebound by the end of the year.

智通财经2026/09/21 09:21
Wall Street’s most steadfast bull warns: If oil prices and the bond market worsen, the S&P 500 may first drop to 7,100 points.

AI boom hides potential correction risks? ECB board member: If expectations fall short, the market will be fragile

Fabio Panetta, a member of the European Central Bank's Governing Council, warned that technology companies are overvalued, which could expose the market to the risk of a significant correction.

智通财经2026/09/21 09:17